Interventional Cardiology Products Market by Key Players & Region

The global interventional cardiology products market is expected to reach USD 20.85 Billion by 2022 from USD 14.52 Billion in 2017, at a CAGR of 7.5%. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices.

The key players in the interventional cardiology products market  include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany).

Target Audience for this interventional cardiology products market 

• Manufacturers and vendors of interventional cardiology devices
• Research associations related to non-communicable diseases
• Various research and consulting firms
• Distributors of interventional cardiology devices
• Contract research manufacturers of interventional cardiology devices
• Healthcare institutions
• Research institutes

The global  interventional cardiology products market  is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered on Japan, China, and India. Factors such as the rising focus of major players in emerging Asia Pacific countries and government support are driving the growth of the interventional cardiology devices market in this region.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

Clinical Workflow Solutions Market worth $12.1 billion by 2023 growing at a CAGR of 12.4%

The growth of this market is mainly driven by the increase in need to curtail healthcare costs and the increasing patient volume due to the rising prevalence of chronic diseases. Also, the advantages of clinical workflow solutions in enhancing patient care and safety along with the government initiatives for HCIT adoption are escalating the market growth.


"Clinical Workflow Solutions Market by Product (Data Integration, EMR Integration, Nurse Call Systems, Unified Communications, Care Solutions, Patient Flow Management, Enterprise Solutions), End Users, and Region - Global Forecast to 2023"


[208 Pages Report] The global clinical workflow solutions market is projected to reach USD 12.1 billion by 2023 from USD 6.8 billion in 2018, at a CAGR of 12.4%

North America is expected to account for the largest share of the clinical workflow solutions market in 2018, followed by Europe. The dominance of the North American region can be attributed to the growing healthcare IT spending, developed infrastructure, evolving regulations for better healthcare outcomes, and the presence of major market players in the region, need to cut healthcare costs and financial support from the government to enhance the quality of healthcare and improve the overall efficiency of healthcare organizations in the region and the presence of a large number of global players in this region.

The prominent players in the clinical workflow solutions market are are Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), and McKesson Corporation (US).

To Know more @ https://www.marketsandmarkets.com/Market-Reports/clinical-workflow-solution-market-146901412.html

Attractive Growth Opportunities in Parkinson's Disease Treatment Market

Parkinson’s disease treatment is used to treat the symptoms of Parkinson’s disease, generally, medication is the first line treatment for this disease.

 The global Parkinson’s disease treatment market is expected to reach USD 5.69 billion by 2022 from USD 4.24 billion in 2017, at a CAGR of 6.1%. Rising geriatric population and government funding for research on Parkinson’s disease are the driving factors for this market.

The Parkinson’s disease treatment market is segmented on the basis of drug class, distribution channel, patient care setting, and region. On the basis of drug class, the Parkinson’s disease treatment market is segmented into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to the potency of the drug.

By distribution channel, the Parkinson’s disease treatment market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. In 2017, the hospital pharmacies segment accounted for the largest share of the market. Increasing number of patient visits to the hospital due to the availability of diagnostic laboratories and presence of skilled neurologists are driving the growth of hospital pharmacies segment.

On the basis of patient care setting, the Parkinson’s disease treatment market is segmented into hospitals and clinics. In 2017, hospitals are expected to account for the largest share of the Parkinson’s disease treatment market. Robust health infrastructure and presence of skilled neurologists are the driving factors for hospital segment.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/parkinson-disease-treatment-market-47265247.html

Environmental Monitoring Market by Product, Region and Key Players - Forecast to 2021

The global environmental monitoring market is expected to reach USD 19.56 Billion by 2021, growing at a CAGR of 7.7% during the forecast period. 

Factors such as increasing government initiatives to control environmental pollution levels, increasing government funding for pollution control and monitoring, ongoing installations of environment monitoring stations, and growing initiatives for the development of environment-friendly industries are driving the growth of the global market.

On the basis of product, the global environmental monitoring market is divided into three major categories, namely, environmental monitors, environmental sensors, and environmental monitoring software. 

The environmental monitor is further divided into two monitoring product segments, namely, fixed monitors and portable monitors. 

The environmental sensors segment is further divided on the basis of product architecture (analog sensors, and digital sensors) and on the basis of applications (temperature sensing, moisture detection, chemical detection, biological detection, particulate detection, and noise measurement). 

On the basis of region, this market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, the global environmental monitoring market is expected to be dominated by North America. Increasing government funding for the maintenance and operation of environmental monitoring stations and the stringent regulations of the U.S. ssEnvironmental Protection Agency (U.S. EPA) are driving the growth of the market in the North American region. 

The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. This is primarily due to rapid industrialization, implementation of increasingly stringent environmental regulation policies, and the growing need to comply with various environmental safety regulations.

As of 2015, Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Honeywell International Inc. (U.S.), Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), TE Connectivity Ltd. (Switzerland), General Electric Company (U.S.), Emerson Electric Co. (U.S.), Teledyne Technologies Inc. (U.S.), and Merck KGaA (Germany)are some key players operating in the global market

To Know More @ https://www.marketsandmarkets.com/Market-Reports/environmental-monitoring-market-216846315.html

Healthcare BI Market: Growth Analysis and Opportunities

 Factors such as the implementation of government initiatives to increase EHR adoption, growing adoption of data-driven decision-making, growing pressure to curb healthcare spending and improve patient outcomes, big data in healthcare, and the increasing number of patient registries are expected to drive the growth of the  healthcare BI market.

The market is highly competitive in nature, with several big as well as emerging players. Prominent players in this market include Microsoft (US), IBM (US), Oracle (US), SAP SE (Germany), SAS Institute Inc. (US), Tableau Software (US), MicroStrategy Incorporated (US), QlikTech International AB (US), Information Builders (US), Sisense Inc. (US), Yellowfin BI (Australia), and BOARD International (Switzerland).

Download FREE Brochure @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=252368925

IBM is one of the key players in the healthcare BI market and provides a comprehensive range of solutions for this market. IBM is an innovation-centric company; its R&D expenditure has increased substantially in 2017 as compared to 2015. In 2017, it invested 7.3% of its annual revenue in R&D activities. This significant investment allows the company to offer innovative solutions by adopting new product launches. With an aim to increase its footprint in various sectors, IBM has adopted inorganic strategies, such as acquisitions, collaborations, and partnerships.

Recent Developments

• In 2018, Oracle acquired Zenedge (US) to secure critical IT systems deployed via cloud, on-premise, or hybrid hosting environments with the help of Zenedge.
• In 2018, SAS entered into an agreement with Deloitte (Canada) to support their existing strategic alliance that will leverage their combined expertise to introduce lower-risk and higher-quality outcomes in the insurance marketplace.
• In 2017, Microsoft partnered with SAP SE (Germany) to drive more business innovation in the cloud and provide joint support services to ensure the best cloud experience for customers.

The market is dominated by North America, followed by Europe, Asia, and RoW. The market in North America is expected to witness the highest growth during the forecast period. The high growth of the North American market can be attributed to the increasing adoption of healthcare intelligence solutions and services by healthcare providers (especially in the US) to provide better quality care and lower healthcare costs is a major factor driving healthcare BI market growth.

To Know More @ https://www.prnewswire.com/news-releases/healthcare-business-intelligence-market-worth-8-9-billion-by-2023-exclusive-report-by-marketsandmarkets-tm--888713562.html

Blood Screening Market is Evolving with High Growth Rate of CAGR 9.6%

.The global blood screening market consists of various technologies and products & services which are used in blood banks and hospitals for the screening of various TTIs.

Blood screening is a medical process in which donated blood is mainly tested for HIV1, HIV2, HBV, HCV, malaria, syphilis, and various other infectious diseases. Donated blood is screened for these infectious diseases to reduce the risk of transfusion-transmitted infections (TTIs)

 The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%.

The major factors driving the growth of this market are increasing number of blood donations and blood donors and rising awareness regarding the safety of donated blood. In addition, increasing affordability and adoption of nucleic acid test (NAT) for blood screening, rising demand for donated blood, and increasing prevalence of infectious diseases are also driving the growth of this market. 

Based on technology, the blood screening market is segmented into NAT, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). The NAT segment is further subsegmented into transcription-mediated amplification (TMA) and real-time PCR. The ELISA segment is further categorized into various platforms and generations.

On the basis of platform, the ELISA market is segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassays (FIA), and colorimetric immunoassay (CI). On the basis of generation, the ELISA market is segmented into first generation ELISA, second generation ELISA, third generation ELISA, and fourth & above generation ELISA.

On the basis of product and service, the blood screening market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment is further divided into NAT reagents and kits, ELISA reagents and kits, and other reagents and kits.

On the basis of purchase mode, the instruments market is segmented into rental purchase and outright purchase. In 2016, the reagents and kits segment is expected to account for the largest share of the blood screening market.

On the basis of end user, the market is segmented into blood banks and hospitals. In 2016, the blood banks segment is expected to account for the largest share of the global blood screening market. Some of the major factors driving the growth of this segment include increasing demand for donated blood and growing number of organ transplantation surgeries around the world.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html

Parkinson's Disease Treatment Market Trending in Pharma Industry

“Parkinson’s disease treatment market projected to grow at a CAGR of 6.1%”

The Parkinson’s disease treatment market is expected to grow from USD 4.24 billion in 2017 to USD 5,694.1 million in 2022 to grow at a CAGR of 6.1%. Factors such as the increasing aging population worldwide and government funding for research on Parkinson’s disease are driving this market. However, the availability of alternative treatments is expected to restrain this market.

“The carbidopa/levodopa segment is expected to register the highest CAGR during the forecast period”

On the basis of drug class, the Parkinson’s disease treatment market is classified into carbidopa/levodopa, dopamine receptor agonists, MAO-inhibitors, COMT-inhibitors, anticholinergics and other drugs. The carbidopa/levodopa segment is expected to register the highest growth rate during the forecast period. The growth of this market segment is mainly driven by its potency and wide adoption in the treatment of Parkinson’s disease.

“The online pharmacies segment to grow at the fastest rate during the forecast period”

By distribution channel type, the Parkinson’s disease treatment market is segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. The online pharmacies segment is expected to register highest CAGR during the forecast period. Advantages such as 24/7 ordering, home delivery, and discounts on medicines are the driving factors for this segment.

“Europe to hold the largest share of the regional market during the forecast period”

Geographically, the Parkinson’s disease treatment market is dominated by Europe, followed by North America, Asia, and the Rest of the World (RoW). Europe is expected to command the largest share of the Parkinson’s disease treatment market. The large share of this segment can be attributed to the growing aging population, presence of key players, and increasing healthcare expenditure in the region. The Asian region is estimated to grow at the fastest rate during the forecast period.

The primary interviews conducted for this report can be categorized as follows:

·         By Company Type - Tier 1 – 70% and Tier 2 – 30%

·         By Designation – C-level – 62%, Director Level – 21%, Others – 17%

·         By Region – North America – 50%, Europe – 20%, Asia – 30%

To Know More @https://www.marketsandmarkets.com/Market-Reports/parkinson-disease-treatment-market-47265247.html

Increasing Number of Interventional Procedures to Drive Hemostasis Valve Market Growth During the Forecast Period

The study involved four major activities to estimate the current market size for the global hemostasis valves market. 

Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

The hemostasis valves market is projected to grow from USD 132 million in 2018 to USD 175 million by 2023, at a CAGR of 5.8% during the forecast period. Growth in the hemostasis valves market is mainly driven by the increasing number of interventional procedures.

North America is one of the major revenue-generating regions in the global hemostasis valves market. The large share of the North American market is attributed to increasing number of interventional surgeries and rising geriatric population.

Hemostasis Valves Market, By Type

§  Hemostasis Valve Y-connectors

§  Double Y-connector Hemostasis Valves

§  One-handed Hemostasis Valves

§  Other Hemostasis Valves

Hemostasis Valves Market, By Application

§  Angiography

§  Angioplasty

Hemostasis Valves Market, By End User

§  Hospitals

§  Other End Users 

To Know More @ https://www.marketsandmarkets.com/Market-Reports/hemostasis-valve-market-206116778.html

IBM is one of the key players provides a comprehensive range of solutions for healthcare business intelligence Market

Key players in healthcare business intelligence market

IBM is one of the key players in the healthcare business intelligence market and provides a comprehensive range of solutions for this market. IBM is an innovation-centric company; its R&D expenditure has increased substantially in 2017 as compared to 2015. In 2017, it invested 7.3% of its annual revenue in R&D activities. This significant investment allows the company to offer innovative solutions by adopting new product launches. With an aim to increase its footprint in various sectors, IBM has adopted inorganic strategies, such as acquisitions, collaborations, and partnerships.

Recent Developments

• In 2018, Oracle acquired Zenedge (US) to secure critical IT systems deployed via cloud, on-premise, or hybrid hosting environments with the help of Zenedge.
• In 2018, SAS entered into an agreement with Deloitte (Canada) to support their existing strategic alliance that will leverage their combined expertise to introduce lower-risk and higher-quality outcomes in the insurance marketplace.
• In 2017, Microsoft partnered with SAP SE (Germany) to drive more business innovation in the cloud and provide joint support services to ensure the best cloud experience for customers.

North America is expected to account for the largest market size during the forecast period

The market is dominated by North America, followed by Europe, Asia, and RoW. The market in North America is expected to witness the highest growth during the forecast period. The high growth of the North American market can be attributed to the increasing adoption of healthcare intelligence solutions and services by healthcare providers (especially in the US) to provide better quality care and lower healthcare costs is a major factor driving market growth.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/healthcare-business-intelligence-market-252368925.html